NDTL receives approval from WADA to manage Athlete Biological Passport

The National Dope Testing Laboratory (NDTL) in New Delhi received approval from the World Anti-Doping Agency (WADA) to manage the Athlete Biological Passport (ABP). This approval marks a significant milestone for India’s anti-doping initiatives and positions NDTL as one of the 17 WADA-approved Athlete Passport Management Units (APMU) worldwide.

The new approach by NDTL to deal with Doping

The Athlete Biological Passport is an advanced anti-doping tool that monitors an athlete’s biological markers over time, including blood and steroid profiles. By analyzing variations in these parameters, the ABP helps ensure fair play in sports and protects clean athletes. This recognition is a matter of great pride for India and strengthens NDTL’s credibility as a key player in the global fight against doping.

“The World Anti-Doping Agency (WADA) has granted approval for the NDTL, New Delhi on 6th December 2024, as an Athlete Passport Management Unit (APMU) to manage the Athlete Biological Passport (ABP),” a PIB release said.

“This milestone marks a significant achievement for India in advancing its anti-doping initiatives. Now, India is part of a group of 17 APMUs approved by WADA worldwide.

“India’s APMU would serve the country as well as the anti-doping organisations of neighbouring countries.”

NDTL’s new role as an APMU will not only serve India but also the anti-doping organizations of neighbouring countries. This development is expected to open new pathways and enhance the effectiveness of anti-doping programs in the region.

Also Read: Saudi Arabia to host 2034 FIFA World Cup